Don't worry about the others bashing your post. I think looking out far enough, maybe 5 years, that the company can be worth $100+ per share. If ACTC can capture the eye market, part of the heart market, the blood market, and part of the hESC market, then ACTC easily can be worth $100 per share. Looks at AAPL and MSFT -- ACTC will be dominant in the stem cell market as MSFT and AAPL are dominant in their respective markets.
But most here are focused on getting out of the sub $1 range and I'm sure many will become almost stemillionaires as they will sell too early as they clearly do not have any vision beyond the next few months.
Look at the entire market for what they are doing....then value the company...sorry peckers don't you have the money to invest in a chance of a lifetime? I don't care if you buy or not....I stated my opinion...
Over billion shares outstanding.....@ $100.00...100 billion cap...lmao...moron,moron ,moron...its people like you that make people like me sell...gl, and sweet dreams,tommorow the nightmare continues,,,lol